Titlebook: Anticancer Drug Development Guide; Preclinical Screenin Beverly A. Teicher (Vice President and Director of Book 2004 Springer Science+Busin

只看該作者 · 發(fā)表于 2025-3-29 04:45:45

Beverly A. Teicher (Vice President and Director ofIncludes supplementary material:

只看該作者 · 發(fā)表于 2025-3-29 09:13:48

只看該作者 · 發(fā)表于 2025-3-29 14:41:12

只看該作者 · 發(fā)表于 2025-3-29 18:21:56

https://doi.org/10.1007/978-1-59259-739-0cancer; cell; clinical trial; drug; drug development; drug discovery; leukemia; research; screening; tumor

只看該作者 · 發(fā)表于 2025-3-29 22:44:03

只看該作者 · 發(fā)表于 2025-3-30 00:16:10

https://doi.org/10.1007/978-3-540-34049-2The classic question in the field of drug discovery is: Which tumor model is a satisfactory predictor for cancer in humans? The classic answer is: None of them!

只看該作者 · 發(fā)表于 2025-3-30 04:02:53

In Vivo Methods for Screening and Preclinical TestingThe classic question in the field of drug discovery is: Which tumor model is a satisfactory predictor for cancer in humans? The classic answer is: None of them!

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-28 16:58
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved